Dallio, M.; Romeo, M.; Di Nardo, F.; Napolitano, C.; Vaia, P.; Basile, C.; Coppola, A.; Silvestrin, A.; Senese, G.; Niosi, M.;
et al. From “MAFLD” to “MASLD”: Was This Revolution Worth It? A Head-to-Head Comparison of MAFLD and MASLD Criteria in Estimating Liver Disease Progression and Cardiovascular Risk in Real Life. Livers 2025, 5, 58.
https://doi.org/10.3390/livers5040058
AMA Style
Dallio M, Romeo M, Di Nardo F, Napolitano C, Vaia P, Basile C, Coppola A, Silvestrin A, Senese G, Niosi M,
et al. From “MAFLD” to “MASLD”: Was This Revolution Worth It? A Head-to-Head Comparison of MAFLD and MASLD Criteria in Estimating Liver Disease Progression and Cardiovascular Risk in Real Life. Livers. 2025; 5(4):58.
https://doi.org/10.3390/livers5040058
Chicago/Turabian Style
Dallio, Marcello, Mario Romeo, Fiammetta Di Nardo, Carmine Napolitano, Paolo Vaia, Claudio Basile, Annachiara Coppola, Alessia Silvestrin, Giusy Senese, Marco Niosi,
and et al. 2025. "From “MAFLD” to “MASLD”: Was This Revolution Worth It? A Head-to-Head Comparison of MAFLD and MASLD Criteria in Estimating Liver Disease Progression and Cardiovascular Risk in Real Life" Livers 5, no. 4: 58.
https://doi.org/10.3390/livers5040058
APA Style
Dallio, M., Romeo, M., Di Nardo, F., Napolitano, C., Vaia, P., Basile, C., Coppola, A., Silvestrin, A., Senese, G., Niosi, M., & Federico, A.
(2025). From “MAFLD” to “MASLD”: Was This Revolution Worth It? A Head-to-Head Comparison of MAFLD and MASLD Criteria in Estimating Liver Disease Progression and Cardiovascular Risk in Real Life. Livers, 5(4), 58.
https://doi.org/10.3390/livers5040058
